Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review
Cancers · 21.02.2023 · 15 (5) · 1362
DOI: 10.3390/cancers15051362 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.02.2023. Verfasst von Alexandra Teixeira und 6 weiteren Autor:innen. Beteiligte Einrichtung: International Iberian Nanotechnology Laboratory (INL), Avda Mestre José Veiga, 4715-310 Braga, Portugal. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by European Regional Development Fund (ERDF) through COMPETE2020, under the Impact-L project, European Commission, Fundação para a Ciência e Tecnologia.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) comprises a group of hematologic neoplasms characterized by abnormal differentiation and proliferation of myeloid progenitor cells. AML is associated with poor outcome due to the lack of efficient therapies and early diagnostic tools. The current gold standard diagnostic tools are based on bone marrow biopsy. These biopsies, apart from being very invasive, painful, and costly, have low sensitivity. Despite the progress uncovering the molecular pathogenesis of AML, the development of novel detection strategies is still poorly explored. This is particularly important for patients that check the criteria for complete remission after treatment, since they can relapse through the persistence of some leukemic stem cells. This condition, recently named as measurable residual disease (MRD), has severe consequences for disease progression. Hence, an early and accurate diagnosis of MRD would allow an appropriate therapy to be tailored, improving a patient’s prognosis. Many novel techniques with high potential in disease prevention and early detection are being explored. Among them, microfluidics has flourished in recent years due to its ability at processing complex samples as well as its demonstrated capacity to isolate rare cells from biological fluids. In parallel, surface-enhanced Raman scattering (SERS) spectroscopy has shown outstanding sensitivity and capability for multiplex quantitative detection of disease biomarkers. Together, these technologies can allow early and cost-effective disease detection as well as contribute to monitoring the efficiency of treatments. In this review, we aim to provide a comprehensive overview of AML disease, the conventional techniques currently used for its diagnosis, classification (recently updated in September 2022), and treatment selection, and we also aim to present how novel technologies can be applied to improve the detection and monitoring of MRD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- International Iberian Nanotechnology Laboratory (INL), Avda Mestre José Veiga, 4715-310 Braga, Portugal.
- Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, 4710-057 Braga, Portugal.
- ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga, Portugal.
ORCID-Profile: Alexandra Teixeira, Sara Abalde-Cela, Belém Sampaio-Marques, Anabela C Areias, Paula Ludovico, Lorena Diéguez
Förderung
- This work was supported by European Regional Development Fund (ERDF) through COMPETE2020, under the Impact-L project
- European Commission
- Fundação para a Ciência e Tecnologia
- Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF)
- La Caixa Foundation
- European Regional Development Fund (ERDF)
- Foundation for Science and Technology (FCT)
- Norte Portugal Regional Operational Programme (NORTE 2020)
Zitieren
APA
Teixeira, A., Carreira, L., Abalde-Cela, S., Sampaio-Marques, B., Areias, A. C., Ludovico, P., & Diéguez, L. (2023). Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review. Cancers, 15(5), 1362. https://doi.org/10.3390/cancers15051362
Vancouver
Teixeira A, Carreira L, Abalde-Cela S, Sampaio-Marques B, Areias AC, Ludovico P, et al. Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review. Cancers. 2023;15(5):1362. doi:10.3390/cancers15051362
BibTeX
@article{Teixeira2023,
author = {Teixeira, Alexandra and Carreira, Luís and Abalde-Cela, Sara and Sampaio-Marques, Belém and Areias, Anabela C and Ludovico, Paula and Diéguez, Lorena},
title = {Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review},
journal = {Cancers},
year = {2023},
volume = {15},
number = {5},
pages = {1362},
doi = {10.3390/cancers15051362}
}
EUVIMED